NCT03739398

Brief Summary

Fractional Microneedle Radiofrequency (FMR) equipment is a device that penetrates the epidermis and irradiates the high frequency by entering the dermis. The generated radiofrequency transfers heat energy and induces thermal denaturation in the surrounding tissue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2019

Completed
Last Updated

September 29, 2020

Status Verified

September 1, 2020

Enrollment Period

8 months

First QC Date

October 30, 2018

Last Update Submit

September 28, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Skin roughness

    The roughness and wrinkle of the skin corresponding to the wrinkles of the outer eyelid

    immediately before the procedure to three months after last procedure

  • wrinkle

    the wrinkle of glabella were measured using an Antera 3D camera and compared

    immediately before the procedure to three months after last procedure

Secondary Outcomes (5)

  • Transepidermal water loss

    immediately before the procedure to three months after last procedure

  • Description of overall manifestation by clinical photo and visiometer

    immediately before the procedure to three months after last procedure

  • Patients' subjective Treatment Satisfaction of the degree of skin aging improvement, wrinkles, pores, skin color, skin elasticity, skin dryness

    immediately before the procedure to three months after last procedure

  • Evaluation of researchers' skin improvement

    immediately before the procedure to three months after last procedure

  • Change of investigator's global assessment of lateral canthal line severity rating

    immediately before the procedure to three months after last procedure

Study Arms (2)

LUTRONIC GENUS laser with LASEMD laser

EXPERIMENTAL
Device: LUTRONIC GENUS laser(Fractional Microneedle Radiofrequency(FMR))

LUTRONIC GENUS laser without LASEMD laser

ACTIVE COMPARATOR
Device: LASEMED laser(The Thulium laser with 1,927nm wavelength)

Interventions

1\. LUTRONIC GENUS laser(Fractional Microneedle Radiofrequency(FMR)) : Fractional Microneedle Radiofrequency (FMR) equipment is a device that penetrates the epidermis and irradiates the high frequency by entering the dermis. The generated radiofrequency transfers heat energy and induces thermal denaturation in the surrounding tissue. Using this principle, FMR equipment is being used as a very effective treatment for scarring, enlarged pores, hyperhidrosis as well as wrinkles. Unlike conventional treatments, FMR equipment has the advantage of a short recovery time after treatment because it minimizes damage to the epidermis because the insulated microspheres penetrate the skin and generate high frequency only at the end of the microspheres.

LUTRONIC GENUS laser with LASEMD laser

2\. LASEMD laser(The Thulium laser with 1,927nm wavelength) The Thulium laser with 1,927nm wavelength is a device that effectively removes various skin diseases present in the epidermis while minimizing the side effects such as scarring and pigmentation because it induces thermal damage to the only skin surface compared to conventional laser equipment. In recent years, not only skin lesions on the epidermis but also pigment disease and wrinkles have been reported to have a good effect. In this study, we investigated the effect and stability of combined treatment of Thulium laser with 1,927nm wavelength in addition to FMR equipment which has already proven to be effective in improving skin aging.

LUTRONIC GENUS laser without LASEMD laser

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy normal adults between 45 and 65 years of age
  • Subjects with moderate to severe wrinkles based on the Investigator's global assessment of lateral canthal line severity rating
  • Subjects who have voluntarily signed a written consent before
  • Subjects who can follow up during the trial
  • Subjects who have agreed to cease all dermatological treatment or treatment, including improvement of neck and face wrinkles, during this trial

You may not qualify if:

  • If subjects do not want it or do not fill out a consent form
  • If subjects are allergic to local anesthetics (lidocaine)
  • Subjects who are Pregnant or lactating
  • Subjects who are deemed to be inadequate as subjects by the clinical investigator for the following patients or other pathologies 1) If the site of treatment has infectious or inflammatory skin disease 2) If the site of treatment has melasma or other pigmented dermatologic disease 3) If subjects have keloid disease, collagen, or elastic fiber disease 4) If subjects have chronic wasting disease (asthma, diabetes, etc.) 5) If subjects are taking anticoagulants and are at risk of bleeding 6) If subjects have an autoimmune disease 7) Subjects with psychiatric problems 8) Acute patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine

Seoul, 03722, South Korea

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: LUTRONIC GENIUS Laser is performed on one side and LASEMD Laser is performed on the other. LUTRONIC GENIUS Laser is performed on the other side without energy irradiation. Laser treatment is performed after application of EMLA cream (2.5% lidocaine 2.5% and prilocaine 2.5%) for 30 minutes or more before local anesthesia. Measurement of hydration, transepidermal water loss, skin pigmentation, redness, and elasticity were performed using a corneometer, a vapometer, a mexameter, and a cutometer before the procedure and on the 7th day after the first operation and 3 months after the last operation. Using an Antera 3D® camera, the skin texture, wrinkles, pores, volume of depressions / elevations, skin color, redness and pigmentation were measured. The change of skin surface and extent of wrinkle were measured using a visuometer, a high-resolution camera.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 13, 2018

Study Start

August 24, 2018

Primary Completion

April 23, 2019

Study Completion

April 23, 2019

Last Updated

September 29, 2020

Record last verified: 2020-09

Locations